Kian Kani Lawrence J. Ellison Institute for Transformative Medicine, Center for Applied Molecular Medicine University of Southern California Biography Publications Institution JoVE Articles Kian Kani has not added a biography. If you are Kian Kani and would like to personalize this page please email our Author Liaison for assistance. Publications Identification, Characterization and Application of a New Peptide Against Anterior Gradient Homolog 2 (AGR2) Oncotarget. Jun, 2018 | Pubmed ID: 29937991 A Blood Biomarker for Monitoring Response to Anti-EGFR Therapy Cancer Biomarkers : Section A of Disease Markers. 2018 | Pubmed ID: 29689709 Protein Mimetic and Anticancer Properties of Monocyte-Targeting Peptide Amphiphile Micelles ACS Biomaterials Science & Engineering. Dec, 2017 | Pubmed ID: 29302619 JUN-Mediated Downregulation of EGFR Signaling Is Associated with Resistance to Gefitinib in EGFR-mutant NSCLC Cell Lines Molecular Cancer Therapeutics. Aug, 2017 | Pubmed ID: 28566434 Androgen Receptor in Cancer-associated Fibroblasts Influences Stemness in Cancer Cells Endocrine-related Cancer. 04, 2017 | Pubmed ID: 28264911 Quantitative Proteomics Using SILAC Methods in Molecular Biology (Clifton, N.J.). 2017 | Pubmed ID: 28188530 Simulation of the Protein-Shedding Kinetics of a Fully Vascularized Tumor Cancer Informatics. 2015 | Pubmed ID: 26715830 Anterior Gradient 2 (AGR2): Blood-based Biomarker Elevated in Metastatic Prostate Cancer Associated with the Neuroendocrine Phenotype The Prostate. Feb, 2013 | Pubmed ID: 22911164 A Cross-platform Toolkit for Mass Spectrometry and Proteomics Nature Biotechnology. Oct, 2012 | Pubmed ID: 23051804 Quantitative Proteomic Profiling Identifies Protein Correlates to EGFR Kinase Inhibition Molecular Cancer Therapeutics. May, 2012 | Pubmed ID: 22411897 Investigation of Acquired Resistance to EGFR-targeted Therapies in Lung Cancer Using CDNA Microarrays Methods in Molecular Biology (Clifton, N.J.). 2012 | Pubmed ID: 21960227 Impact of Protein Stability, Cellular Localization, and Abundance on Proteomic Detection of Tumor-derived Proteins in Plasma PloS One. 2011 | Pubmed ID: 21829587 Model-based Discovery of Circulating Biomarkers Methods in Molecular Biology (Clifton, N.J.). 2011 | Pubmed ID: 21468942 Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays Katrin Tiemann1, Carolina Garri1, Jeffrey Wang1, Lauren Clarke1, Kian Kani1 1Lawrence J. Ellison Institute for Transformative Medicine, Center for Applied Molecular Medicine, University of Southern California JoVE 57779 Cancer Research
Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays Katrin Tiemann1, Carolina Garri1, Jeffrey Wang1, Lauren Clarke1, Kian Kani1 1Lawrence J. Ellison Institute for Transformative Medicine, Center for Applied Molecular Medicine, University of Southern California JoVE 57779 Cancer Research
